Search research articles
Contact Us
Filters
Showing results (581-590 of 4,678) with videos related to
Page
of 468
Sort By:
Cancer Discovery
|
October 15, 2014
Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer
Simon Junankar, Gemma Shay, Julie Jurczyluk, et al.
Cancer Discovery
|
June 19, 2013
ZNF365 promotes stability of fragile sites and telomeres
Yuqing Zhang, Sandra J Shin, Debra Liu, et al.
Cancer Discovery
|
June 20, 2013
A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509
James D Joseph, Nhin Lu, Jing Qian, et al.
Cancer Discovery
|
May 2, 2013
Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1
Raúl Catena, Nandita Bhattacharya, Tina El Rayes, et al.
Cancer Discovery
|
June 15, 2013
Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers
Daniel Hagerstrand, Alexander Tong, Steven E Schumacher, et al.
Cancer Discovery
|
June 11, 2013
Q&A: Ashok Venkitaraman on "undruggable" targets. Interview by Eric Bender
Ashok Venkitaraman
Cancer Discovery
|
June 11, 2013
The new kid on the block: RET in lung cancer
Justin F Gainor, Alice T Shaw
Cancer Discovery
|
June 11, 2013
FGFR fusions in the driver's seat
Amit J Sabnis, Trever G Bivona
Cancer Discovery
|
June 11, 2013
A new alpha in line between KRAS and NF-κB activation?
Chorom Pak, Shigeki Miyamoto
Cancer Discovery
|
September 28, 2013
ceRNA cross-talk in cancer: when ce-bling rivalries go awry
Florian A Karreth, Pier Paolo Pandolfi
Page
of 468
Search research articles
Search
Showing results (581-590 of 4,678) with videos related to
Sort By:
Page
of 468
Cancer Discovery
|
October 15, 2014
Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer
Simon Junankar, Gemma Shay, Julie Jurczyluk, et al.
Cancer Discovery
|
June 19, 2013
ZNF365 promotes stability of fragile sites and telomeres
Yuqing Zhang, Sandra J Shin, Debra Liu, et al.
Cancer Discovery
|
June 20, 2013
A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509
James D Joseph, Nhin Lu, Jing Qian, et al.
Cancer Discovery
|
May 2, 2013
Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1
Raúl Catena, Nandita Bhattacharya, Tina El Rayes, et al.
Cancer Discovery
|
June 15, 2013
Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers
Daniel Hagerstrand, Alexander Tong, Steven E Schumacher, et al.
Cancer Discovery
|
June 11, 2013
Q&A: Ashok Venkitaraman on "undruggable" targets. Interview by Eric Bender
Ashok Venkitaraman
Cancer Discovery
|
June 11, 2013
The new kid on the block: RET in lung cancer
Justin F Gainor, Alice T Shaw
Cancer Discovery
|
June 11, 2013
FGFR fusions in the driver's seat
Amit J Sabnis, Trever G Bivona
Cancer Discovery
|
June 11, 2013
A new alpha in line between KRAS and NF-κB activation?
Chorom Pak, Shigeki Miyamoto
Cancer Discovery
|
September 28, 2013
ceRNA cross-talk in cancer: when ce-bling rivalries go awry
Florian A Karreth, Pier Paolo Pandolfi
Page
of 468